While there is no treatment for trichomoniasis, there is currently one vaccine available that has been proven to aid in the prevention of disease caused by Tritrichomonas foetus. TrichGuard® and TrichGuard® V5L, available from Boehringer Ingelheim Vetmedica, Inc., are the first vaccines to protect against T. foetus devastation.

In a university study, TrichGuard improved calving percentages by more than 90 percent compared to unvaccinated cows.1 While it won’t prevent trichomoniasis in your cowherd, vaccinating with TrichGuard vaccine will help lessen its impact and reduce calving losses resulting from trichomoniasis.In this same research, vaccination with TrichGuard stimulated a local antibody response in vaccinates. Reports also demonstrate that anti-trich antibodies such as these are found in the reproductive-tract secretions of infected individuals.

Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, MO) is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT, and a member of the Boehringer Ingelheim group of companies.